[Form 4] USANA Health Sciences Inc Insider Trading Activity
USANA Health Sciences (USNA) 鈥� Form 4 filing
On 24-Jul-2025, CEO & President Jim Brown converted 2,190 previously granted restricted stock units (code 鈥淢鈥�) into an equal number of common shares. To satisfy withholding taxes, 972 of those shares were automatically surrendered to the issuer at $32.09 per share (code 鈥淔鈥�). The net effect is an increase of 1,218 directly held shares, bringing Brown鈥檚 direct common-stock ownership to 16,934. He also retains 160,878 unvested/derivative RSUs that will convert into common shares as they vest. No open-market purchases or sales occurred; all transactions were internal equity-compensation settlements. The filing does not disclose any broader corporate developments.
USANA Health Sciences (USNA) 鈥� Deposito Form 4
Il 24 luglio 2025, il CEO e Presidente Jim Brown ha convertito 2.190 unit脿 azionarie vincolate precedentemente assegnate (codice 鈥淢鈥�) in un numero uguale di azioni ordinarie. Per coprire le imposte di ritenuta, 972 di queste azioni sono state automaticamente restituite all'emittente al prezzo di $32,09 per azione (codice 鈥淔鈥�). L'effetto netto 猫 un aumento di 1.218 azioni detenute direttamente, portando la propriet脿 diretta di azioni ordinarie di Brown a 16.934. Mantiene inoltre 160.878 RSU non maturate/derivate che si convertiranno in azioni ordinarie al momento della maturazione. Non sono stati effettuati acquisti o vendite sul mercato aperto; tutte le transazioni sono state regolamenti interni di compensazione azionaria. Il deposito non rivela sviluppi aziendali pi霉 ampi.
USANA Health Sciences (USNA) 鈥� Presentaci贸n Formulario 4
El 24 de julio de 2025, el CEO y Presidente Jim Brown 肠辞苍惫颈谤迟颈贸 2,190 unidades de acciones restringidas previamente otorgadas (c贸digo 鈥淢鈥�) en un n煤mero igual de acciones comunes. Para cubrir los impuestos retenidos, 972 de esas acciones fueron autom谩ticamente entregadas al emisor a $32.09 por acci贸n (c贸digo 鈥淔鈥�). El efecto neto es un aumento de 1,218 acciones en propiedad directa, elevando la tenencia directa de acciones comunes de Brown a 16,934. Adem谩s, conserva 160,878 RSU no adquiridas/derivadas que se convertir谩n en acciones comunes a medida que vayan madurando. No se realizaron compras ni ventas en el mercado abierto; todas las transacciones fueron liquidaciones internas de compensaci贸n accionaria. La presentaci贸n no revela ning煤n desarrollo corporativo m谩s amplio.
USANA Health Sciences (USNA) 鈥� Form 4 鞝滌稖
2025雲� 7鞗� 24鞚�, CEO 瓴� 靷灔 Jim Brown鞚� 鞚挫爠鞐� 攵�鞐悳 鞝滍暅 欤检嫕 雼渼(RSU) 2,190臧�(旖旊摐 鈥淢鈥�)毳� 霃欖澕頃� 靾橃潣 氤错喌欤茧 鞝勴櫂頄堨姷雼堧嫟. 鞗愳矞歆曥垬靹鸽ゼ 於╇嫻頃橁赴 鞙勴暣 972欤缄皜 欤茧嫻 $32.09(旖旊摐 鈥淔鈥�)鞐� 氚滍枆靷棎 鞛愲彊鞙茧 氚橅櫂霅橃棃鞀惦媹雼�. 靾滍毃瓿茧姅 歆侅爲 氤挫湢 欤检嫕鞚� 1,218欤� 歃濌皜頃橃棳 Brown鞚� 歆侅爲 氤错喌欤� 氤挫湢霟夓澊 16,934欤缄皜 霅橃棃鞀惦媹雼�. 霕愴暅 鞎勳 旆摑頃橃 鞎婌潃/韺岇儩霅� RSU 160,878欤茧ゼ 氤挫湢頃橁碃 鞛堨溂氅�, 鞚措摛鞚� 旆摑 鞁� 氤错喌欤茧 鞝勴櫂霅╇媹雼�. 瓿店皽 鞁滌灔鞐愳劀鞚� 毵るГ電� 鞐嗢棃鞙茧┌, 氇摖 瓯半灅電� 雮措秬 欤检嫕 氤挫儊 鞝曥偘鞚挫棃鞀惦媹雼�. 鞚措矆 鞝滌稖靹滊鞐愳劀電� 雿� 雱撿潃 旮办梾 甏�霠� 氚滌爠 靷暛鞚� 瓿店皽霅橃 鞎婌晿鞀惦媹雼�.
USANA Health Sciences (USNA) 鈥� D茅p么t du Formulaire 4
Le 24 juillet 2025, le PDG et Pr茅sident Jim Brown a converti 2 190 unit茅s d鈥檃ctions restreintes pr茅c茅demment attribu茅es (code 芦 M 禄) en un nombre 茅gal d鈥檃ctions ordinaires. Pour couvrir les imp么ts 脿 la source, 972 de ces actions ont 茅t茅 automatiquement remises 脿 l鈥櫭﹎etteur au prix de 32,09 $ par action (code 芦 F 禄). L鈥檈ffet net est une augmentation de 1 218 actions d茅tenues directement, portant la d茅tention directe d鈥檃ctions ordinaires de Brown 脿 16 934. Il conserve 茅galement 160 878 RSU non acquises/d茅riv茅es qui seront converties en actions ordinaires 脿 mesure de leur acquisition. Aucune transaction sur le march茅 ouvert n鈥檃 eu lieu ; toutes les op茅rations 茅taient des r猫glements internes li茅s 脿 la r茅mun茅ration en actions. Le d茅p么t ne r茅v猫le aucun d茅veloppement corporatif plus large.
USANA Health Sciences (USNA) 鈥� Form 4 Einreichung
Am 24. Juli 2025 wandelte CEO und Pr盲sident Jim Brown 2.190 zuvor gew盲hrte Restricted Stock Units (Code 鈥濵鈥�) in eine gleiche Anzahl von Stammaktien um. Zur Begleichung der Quellensteuer wurden 972 dieser Aktien automatisch zum Preis von $32,09 pro Aktie (Code 鈥濬鈥�) an den Emittenten zur眉ckgegeben. Der Nettoeffekt ist eine Erh枚hung von 1.218 direkt gehaltenen Aktien, womit Browns direkter Stammaktienbesitz auf 16.934 steigt. Er h盲lt au脽erdem 160.878 nicht f盲llige/abgeleitete RSUs, die bei F盲lligkeit in Stammaktien umgewandelt werden. Es fanden keine K盲ufe oder Verk盲ufe am offenen Markt statt; alle Transaktionen waren interne Abrechnungen von Aktienverg眉tungen. Die Einreichung enth盲lt keine Hinweise auf weitergehende unternehmerische Entwicklungen.
- CEO Jim Brown increased his direct ownership by 1,218 shares, indicating continued alignment with shareholders.
- A substantial pool of 160,878 RSUs remains, tying executive compensation to future share performance.
- 972 shares were immediately surrendered for tax withholding, reducing the net share increase.
Insights
TL;DR: Routine RSU vesting; CEO nets 1,218 shares, overall impact neutral.
The transaction reflects a scheduled vesting event rather than discretionary buying or selling. Brown鈥檚 gross conversion of 2,190 RSUs and tax withholding of 972 shares is standard practice. His post-transaction holding of 16,934 shares remains small relative to the 160,878 RSUs still outstanding, implying most of his equity upside is tied to future company performance. Because no open-market activity or new grants are involved, dilution and market-signal effects are minimal. From an investor viewpoint the filing is not materially impactful but confirms ongoing insider alignment via equity retention.
USANA Health Sciences (USNA) 鈥� Deposito Form 4
Il 24 luglio 2025, il CEO e Presidente Jim Brown ha convertito 2.190 unit脿 azionarie vincolate precedentemente assegnate (codice 鈥淢鈥�) in un numero uguale di azioni ordinarie. Per coprire le imposte di ritenuta, 972 di queste azioni sono state automaticamente restituite all'emittente al prezzo di $32,09 per azione (codice 鈥淔鈥�). L'effetto netto 猫 un aumento di 1.218 azioni detenute direttamente, portando la propriet脿 diretta di azioni ordinarie di Brown a 16.934. Mantiene inoltre 160.878 RSU non maturate/derivate che si convertiranno in azioni ordinarie al momento della maturazione. Non sono stati effettuati acquisti o vendite sul mercato aperto; tutte le transazioni sono state regolamenti interni di compensazione azionaria. Il deposito non rivela sviluppi aziendali pi霉 ampi.
USANA Health Sciences (USNA) 鈥� Presentaci贸n Formulario 4
El 24 de julio de 2025, el CEO y Presidente Jim Brown 肠辞苍惫颈谤迟颈贸 2,190 unidades de acciones restringidas previamente otorgadas (c贸digo 鈥淢鈥�) en un n煤mero igual de acciones comunes. Para cubrir los impuestos retenidos, 972 de esas acciones fueron autom谩ticamente entregadas al emisor a $32.09 por acci贸n (c贸digo 鈥淔鈥�). El efecto neto es un aumento de 1,218 acciones en propiedad directa, elevando la tenencia directa de acciones comunes de Brown a 16,934. Adem谩s, conserva 160,878 RSU no adquiridas/derivadas que se convertir谩n en acciones comunes a medida que vayan madurando. No se realizaron compras ni ventas en el mercado abierto; todas las transacciones fueron liquidaciones internas de compensaci贸n accionaria. La presentaci贸n no revela ning煤n desarrollo corporativo m谩s amplio.
USANA Health Sciences (USNA) 鈥� Form 4 鞝滌稖
2025雲� 7鞗� 24鞚�, CEO 瓴� 靷灔 Jim Brown鞚� 鞚挫爠鞐� 攵�鞐悳 鞝滍暅 欤检嫕 雼渼(RSU) 2,190臧�(旖旊摐 鈥淢鈥�)毳� 霃欖澕頃� 靾橃潣 氤错喌欤茧 鞝勴櫂頄堨姷雼堧嫟. 鞗愳矞歆曥垬靹鸽ゼ 於╇嫻頃橁赴 鞙勴暣 972欤缄皜 欤茧嫻 $32.09(旖旊摐 鈥淔鈥�)鞐� 氚滍枆靷棎 鞛愲彊鞙茧 氚橅櫂霅橃棃鞀惦媹雼�. 靾滍毃瓿茧姅 歆侅爲 氤挫湢 欤检嫕鞚� 1,218欤� 歃濌皜頃橃棳 Brown鞚� 歆侅爲 氤错喌欤� 氤挫湢霟夓澊 16,934欤缄皜 霅橃棃鞀惦媹雼�. 霕愴暅 鞎勳 旆摑頃橃 鞎婌潃/韺岇儩霅� RSU 160,878欤茧ゼ 氤挫湢頃橁碃 鞛堨溂氅�, 鞚措摛鞚� 旆摑 鞁� 氤错喌欤茧 鞝勴櫂霅╇媹雼�. 瓿店皽 鞁滌灔鞐愳劀鞚� 毵るГ電� 鞐嗢棃鞙茧┌, 氇摖 瓯半灅電� 雮措秬 欤检嫕 氤挫儊 鞝曥偘鞚挫棃鞀惦媹雼�. 鞚措矆 鞝滌稖靹滊鞐愳劀電� 雿� 雱撿潃 旮办梾 甏�霠� 氚滌爠 靷暛鞚� 瓿店皽霅橃 鞎婌晿鞀惦媹雼�.
USANA Health Sciences (USNA) 鈥� D茅p么t du Formulaire 4
Le 24 juillet 2025, le PDG et Pr茅sident Jim Brown a converti 2 190 unit茅s d鈥檃ctions restreintes pr茅c茅demment attribu茅es (code 芦 M 禄) en un nombre 茅gal d鈥檃ctions ordinaires. Pour couvrir les imp么ts 脿 la source, 972 de ces actions ont 茅t茅 automatiquement remises 脿 l鈥櫭﹎etteur au prix de 32,09 $ par action (code 芦 F 禄). L鈥檈ffet net est une augmentation de 1 218 actions d茅tenues directement, portant la d茅tention directe d鈥檃ctions ordinaires de Brown 脿 16 934. Il conserve 茅galement 160 878 RSU non acquises/d茅riv茅es qui seront converties en actions ordinaires 脿 mesure de leur acquisition. Aucune transaction sur le march茅 ouvert n鈥檃 eu lieu ; toutes les op茅rations 茅taient des r猫glements internes li茅s 脿 la r茅mun茅ration en actions. Le d茅p么t ne r茅v猫le aucun d茅veloppement corporatif plus large.
USANA Health Sciences (USNA) 鈥� Form 4 Einreichung
Am 24. Juli 2025 wandelte CEO und Pr盲sident Jim Brown 2.190 zuvor gew盲hrte Restricted Stock Units (Code 鈥濵鈥�) in eine gleiche Anzahl von Stammaktien um. Zur Begleichung der Quellensteuer wurden 972 dieser Aktien automatisch zum Preis von $32,09 pro Aktie (Code 鈥濬鈥�) an den Emittenten zur眉ckgegeben. Der Nettoeffekt ist eine Erh枚hung von 1.218 direkt gehaltenen Aktien, womit Browns direkter Stammaktienbesitz auf 16.934 steigt. Er h盲lt au脽erdem 160.878 nicht f盲llige/abgeleitete RSUs, die bei F盲lligkeit in Stammaktien umgewandelt werden. Es fanden keine K盲ufe oder Verk盲ufe am offenen Markt statt; alle Transaktionen waren interne Abrechnungen von Aktienverg眉tungen. Die Einreichung enth盲lt keine Hinweise auf weitergehende unternehmerische Entwicklungen.
FAQ
What insider transaction did USNA file on Form 4 dated 07/24/2025?
How many USNA shares does Jim Brown own after the transaction?
At what price were the withheld USNA shares valued?
How many restricted stock units does the CEO still hold?
Was this an open-market purchase or sale of USNA stock?
